| Joanne Petit-homme, RN | |
|
261 Connecticut Dr, Suite 5, Burlington, NJ 08016-4177 | |
| (800) 950-6066 | |
| Not Available |
| Full Name | Joanne Petit-homme |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 261 Connecticut Dr, Burlington, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013118538 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR11313700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joanne Petit-homme, RN 6724 Grant Ave, Pennsauken, NJ 08109-2458 Ph: (908) 943-7637 | Joanne Petit-homme, RN 261 Connecticut Dr, Suite 5, Burlington, NJ 08016-4177 Ph: (800) 950-6066 |
News Archive
The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of the phase III RACE trial during EBMTs virtual 46th Annual Meeting. Preliminary data show that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with Severe Aplastic Anaemia.
Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation's U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet - non-alcoholic fatty liver disease.
Cancer and type 2 diabetes are two of the most significant public health burdens facing the world today, and currently available data suggests their prevalence is expected to continue to increase. Nut consumption has long been hypothesized to have a role in preventing both of these diseases, but until now evidence has been inconsistent.
› Verified 9 days ago
Jacqueline Lee Todd, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr Ste 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Constantin Vintilescu, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr, Suite 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Karen Coley, LPN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr, Suite 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Leonida D. Matibag, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr Ste 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Marcia Greyson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 328 High St, Burlington, NJ 08016 Phone: 929-557-9059 | |
Mrs. Esther A Woods-bartels, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1003 Sunset Rd, Burlington, NJ 08016 Phone: 856-520-9875 Fax: 732-510-5976 |